Medicare and Medicaid
Other featured articles
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
Research from Schaeffer Center experts Darius Lakdawalla and Meng Li in JAMA Network Open finds U.S. insurers could use drug manufacturer rebates to lower retail pharmacy prices and reduce patient out-of-pocket burden by 38% on average, or 70% in the most competitive drug classes.
Advance Care Planning for Medicare Beneficiaries Increased Substantially, but Prevalence Remained Low
Researchers examined fee-for-service Medicare claims and found a substantial increase in outpatient advance care planning claims between 2016 and 2019, although prevalence remained below 7.5 percent for all patient subgroups analyzed.
Medicare Advanced Imaging Payment: Dysfunctional Policy Making
USC-Brookings Schaeffer Initiative for Health Policy offers three recommendations for improving Medicare’s treatment of advanced imaging in ambulatory settings, two of which focus on setting prices and one on managing utilization.
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.